Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist… GlobalData Aug 9, 2024 Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…
Sun Pharma’s Utreglutide shows weight loss, gluco-metabolic and lipid-lowering efficacy EP News Bureau Jun 24, 2024 GL0034 (Utreglutide) administered once weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters…
Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms Reuters Jan 25, 2023 The company has been struggling to meet strong demand for its incretin products, which include its diabetes drug Trulicity and…
